Scholarlink

<p>Immunotherapy is transforming the treatment of cancer by activating and directing a patient’s own immune response to target tumor cells. In solid tumors, however, there has been limited success in sustaining anti-tumor immune responses. This is attributed to the intrinsic features of the tumor microenvironment, including the lack of infiltrating immune cells and varying expression of tumor antigens, forming an immunosuppressive landscape. Despite recent advances, we do not fully understand how the immune components of the tumor microenvironment are linked to ineffective treatment outcomes. Advanced 3D cancer models offer a platform to deconstruct tumor tissues and study disease progression and resistance to treatment, helping to uncover drivers of immune evasion in a physiologically relevant context. Here, we discuss aspects of the tumor immune microenvironment in selected solid tumors defined by distinct immunosuppressive features that dictate response to immunotherapy. We highlight how advanced 3D cancer models accelerate the development and screening of therapeutic strategies that target the immunosuppressive microenvironment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Advanced 3D cancer models for analyzing tumor-immune cell interaction and therapeutic response

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月19日

查看全文
  • Sree Priyanka Jeevanandan,
  • Eileen Reidy,
  • Julien Clegg,
  • Rodrigo Curvello,
  • Aideen E Ryan,
  • Daniela Loessner

摘要

Immunotherapy is transforming the treatment of cancer by activating and directing a patient’s own immune response to target tumor cells. In solid tumors, however, there has been limited success in sustaining anti-tumor immune responses. This is attributed to the intrinsic features of the tumor microenvironment, including the lack of infiltrating immune cells and varying expression of tumor antigens, forming an immunosuppressive landscape. Despite recent advances, we do not fully understand how the immune components of the tumor microenvironment are linked to ineffective treatment outcomes. Advanced 3D cancer models offer a platform to deconstruct tumor tissues and study disease progression and resistance to treatment, helping to uncover drivers of immune evasion in a physiologically relevant context. Here, we discuss aspects of the tumor immune microenvironment in selected solid tumors defined by distinct immunosuppressive features that dictate response to immunotherapy. We highlight how advanced 3D cancer models accelerate the development and screening of therapeutic strategies that target the immunosuppressive microenvironment.